{"transactions":[{"id":683470,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Performance Stock Units","published_at":"2026-08-19T00:28:55.000Z","date":"2026-08-14","kind":"exercise","planned":false,"acquired":false,"shares":26250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each performance stock unit represents a right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Achievement of this performance stock unit award was certified on August 14, 2025.  Pursuant to the terms of the award agreement between the reporting person and the Issuer, half the award vested on August 14, 2025 and the remainder vests on August 14, 2026, subject to the reporting person's continued service to the Issuer on the relevant vesting date."}],"balance_after":0,"derivative":{"expiration_date":"2026-08-14","underlying":"Common Stock","underlying_shares":26250},"source":{"system":"sec-edgar","filing":"0001522780-26-000007","document":"form4-08192026_120851.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278026000007/form4-08192026_120851.xml","form_type":"4"}},{"id":683469,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-19T00:28:55.000Z","date":"2026-08-18","kind":"sale","planned":false,"acquired":false,"shares":637,"price":32.4681,"value":20682.1797,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.44 to $32.54 per share, inclusive."}],"balance_after":124557,"source":{"system":"sec-edgar","filing":"0001522780-26-000007","document":"form4-08192026_120851.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278026000007/form4-08192026_120851.xml","form_type":"4"}},{"id":683468,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-19T00:28:55.000Z","date":"2026-08-18","kind":"sale","planned":false,"acquired":false,"shares":11930,"price":32.0072,"value":381845.896,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.40 to $32.36 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4."}],"balance_after":125194,"source":{"system":"sec-edgar","filing":"0001522780-26-000007","document":"form4-08192026_120851.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278026000007/form4-08192026_120851.xml","form_type":"4"}},{"id":683467,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-19T00:28:55.000Z","date":"2026-08-14","kind":"exercise","planned":false,"acquired":true,"shares":26250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":137124,"source":{"system":"sec-edgar","filing":"0001522780-26-000007","document":"form4-08192026_120851.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278026000007/form4-08192026_120851.xml","form_type":"4"}},{"id":708346,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-16T20:32:49.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":151,"price":82.62,"value":12475.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of common stock granted pursuant to the Cytokinetics Equity in lieu of Cash Retainer Program. Shares are fully vested at the time of grant."}],"balance_after":10434,"source":{"system":"sec-edgar","filing":"0001061983-26-000081","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000081/form4.xml","form_type":"4"}},{"id":747886,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-06-05T20:27:57.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":17786,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full on the earlier of:  (i) June 3, 2027 or (ii) the date of the issuer's next annual meeting of its stockholders, subject to the reporting person's continued service to the issuer on the vesting date."}],"balance_after":17786,"derivative":{"exercise_price":29.46,"expiration_date":"2036-06-02","underlying":"Common Stock","underlying_shares":17786},"source":{"system":"sec-edgar","filing":"0001522780-26-000004","document":"form4-06052026_080652.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278026000004/form4-06052026_080652.xml","form_type":"4"}},{"id":757670,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-01T22:54:01.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":2933,"price":76.09,"value":223171.97,"ownership":{"direct":true},"balance_after":10283,"source":{"system":"sec-edgar","filing":"0001061983-26-000066","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000066/form4.xml","form_type":"4"}},{"id":762477,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-05-27T23:11:40.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":4301,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4301,"derivative":{"exercise_price":77.15,"exercise_date":"2026-06-27","expiration_date":"2036-05-26","underlying":"Common Stock","underlying_shares":4301},"source":{"system":"sec-edgar","filing":"0001061983-26-000058","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000058/form4.xml","form_type":"4"}},{"id":762476,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-27T23:11:40.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":2851,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13216,"source":{"system":"sec-edgar","filing":"0001061983-26-000058","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000058/form4.xml","form_type":"4"}},{"id":808346,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-04-15T22:35:34.000Z","date":"2026-04-15","kind":"grant","planned":false,"acquired":true,"shares":191,"price":65.37,"value":12485.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of common stock granted pursuant to Director Equity in Lieu of Cash Retainer Program. Shares are fully vested."}],"balance_after":10365,"source":{"system":"sec-edgar","filing":"0001061983-26-000040","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000040/form4.xml","form_type":"4"}},{"id":837851,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:24:32.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":26250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The award vested or vests as to 1/4 of the total award annually beginning on March 15, 2025, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":52500,"derivative":{"expiration_date":"2028-03-15","underlying":"Common Stock","underlying_shares":26250},"source":{"system":"sec-edgar","filing":"0001522780-26-000002","document":"form4-03172026_090329.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278026000002/form4-03172026_090329.xml","form_type":"4"}},{"id":837850,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:24:32.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":35500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award vested or vests as to 1/4 of the total shares annually beginning March 15, 2024, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":35500,"derivative":{"expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":35500},"source":{"system":"sec-edgar","filing":"0001522780-26-000002","document":"form4-03172026_090329.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278026000002/form4-03172026_090329.xml","form_type":"4"}},{"id":837849,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-17T21:24:32.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":true,"shares":26250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":110874,"source":{"system":"sec-edgar","filing":"0001522780-26-000002","document":"form4-03172026_090329.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278026000002/form4-03172026_090329.xml","form_type":"4"}},{"id":837848,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-17T21:24:32.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":true,"shares":35500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":84624,"source":{"system":"sec-edgar","filing":"0001522780-26-000002","document":"form4-03172026_090329.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278026000002/form4-03172026_090329.xml","form_type":"4"}},{"id":876712,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-27T19:51:10.000Z","date":"2026-02-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":9534,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."}],"balance_after":0,"derivative":{"exercise_price":0.42,"expiration_date":"2029-08-27","underlying":"Common Stock","underlying_shares":9534},"source":{"system":"sec-edgar","filing":"0001193125-26-082136","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1522780/000119312526082136/ownership.xml","form_type":"4"}},{"id":876711,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-27T19:51:10.000Z","date":"2026-02-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":11323,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."}],"balance_after":0,"derivative":{"exercise_price":8.82,"expiration_date":"2030-05-14","underlying":"Common Stock","underlying_shares":11323},"source":{"system":"sec-edgar","filing":"0001193125-26-082136","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1522780/000119312526082136/ownership.xml","form_type":"4"}},{"id":876710,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-27T19:51:10.000Z","date":"2026-02-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."}],"balance_after":0,"derivative":{"exercise_price":26.09,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193125-26-082136","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1522780/000119312526082136/ownership.xml","form_type":"4"}},{"id":876709,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-27T19:51:10.000Z","date":"2026-02-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."}],"balance_after":0,"derivative":{"exercise_price":12.03,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001193125-26-082136","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1522780/000119312526082136/ownership.xml","form_type":"4"}},{"id":876708,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-27T19:51:10.000Z","date":"2026-02-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."}],"balance_after":0,"derivative":{"exercise_price":12.48,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001193125-26-082136","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1522780/000119312526082136/ownership.xml","form_type":"4"}},{"id":876707,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-27T19:51:10.000Z","date":"2026-02-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":13489,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."}],"balance_after":0,"derivative":{"exercise_price":39.96,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":13489},"source":{"system":"sec-edgar","filing":"0001193125-26-082136","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1522780/000119312526082136/ownership.xml","form_type":"4"}},{"id":876706,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-27T19:51:10.000Z","date":"2026-02-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10034,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."}],"balance_after":0,"derivative":{"exercise_price":33.62,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":10034},"source":{"system":"sec-edgar","filing":"0001193125-26-082136","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1522780/000119312526082136/ownership.xml","form_type":"4"}},{"id":876705,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-27T19:51:10.000Z","date":"2026-02-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":6692,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities represent shares of Common Stock (inclusive of shares of Common Stock issuable upon settlement of previously reported restricted stock units) disposed of pursuant to the terms of the Agreement and Plan of Merger, dated as of October 25, 2025 (the \"Merger Agreement\"), among Novartis AG (\"Novartis\"), Ajax Acquisition Sub, Inc., an indirect wholly owned subsidiary of Novartis, and the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities represent shares of Common Stock (inclusive of shares of Common Stock issuable upon settlement of previously reported restricted stock units) disposed of pursuant to the terms of the Agreement and Plan of Merger, dated as of October 25, 2025 (the \"Merger Agreement\"), among Novartis AG (\"Novartis\"), Ajax Acquisition Sub, Inc., an indirect wholly owned subsidiary of Novartis, and the Issuer."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-082136","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1522780/000119312526082136/ownership.xml","form_type":"4"}},{"id":937669,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-01-16T21:18:57.000Z","date":"2026-01-15","kind":"grant","planned":false,"acquired":true,"shares":197,"price":63.44,"value":12497.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Fully vested shares of common stock received in lieu of cash retainer pursuant to Equity in Lieu of Cash Retainer Option available to members of our Board of Directors."}],"balance_after":10174,"source":{"system":"sec-edgar","filing":"0001061983-26-000006","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000006/form4.xml","form_type":"4"}},{"id":974388,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-10T21:23:45.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":1331,"price":33.1041,"value":44061.5571,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.25 per share, inclusive."}],"balance_after":49124,"source":{"system":"sec-edgar","filing":"0001522780-25-000010","document":"form4-12102025_091241.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278025000010/form4-12102025_091241.xml","form_type":"4"}},{"id":974387,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-10T21:23:45.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":8274,"price":32.52,"value":269070.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.95 per share, inclusive."}],"balance_after":50455,"source":{"system":"sec-edgar","filing":"0001522780-25-000010","document":"form4-12102025_091241.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278025000010/form4-12102025_091241.xml","form_type":"4"}},{"id":974386,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-10T21:23:45.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":3825,"price":31.4387,"value":120253.0275,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.00 to $31.90 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 2 and 3 of this Form 4."}],"balance_after":58729,"source":{"system":"sec-edgar","filing":"0001522780-25-000010","document":"form4-12102025_091241.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278025000010/form4-12102025_091241.xml","form_type":"4"}},{"id":979001,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Performance Stock Units","published_at":"2025-12-06T01:50:19.000Z","date":"2025-12-03","kind":"exercise","planned":true,"acquired":false,"shares":26250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Half the award vested on December 3, 2024 and the remainder vested or vests on December 3, 2025, subject to the reporting person's continued service to the Issuer on the relevant vesting date."}],"balance_after":0,"derivative":{"expiration_date":"2025-12-03","underlying":"Common Stock","underlying_shares":26250},"source":{"system":"sec-edgar","filing":"0001522780-25-000009","document":"form4-12062025_011216.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278025000009/form4-12062025_011216.xml","form_type":"4"}},{"id":979000,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-06T01:50:19.000Z","date":"2025-12-05","kind":"sale","planned":true,"acquired":false,"shares":500,"price":31.846,"value":15923.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.70 to $31.96 per share, inclusive."}],"balance_after":62554,"source":{"system":"sec-edgar","filing":"0001522780-25-000009","document":"form4-12062025_011216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278025000009/form4-12062025_011216.xml","form_type":"4"}},{"id":978999,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-06T01:50:19.000Z","date":"2025-12-05","kind":"sale","planned":true,"acquired":false,"shares":1681,"price":31.1468,"value":52357.7708,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.69 to $31.61 per share, inclusive."}],"balance_after":63054,"source":{"system":"sec-edgar","filing":"0001522780-25-000009","document":"form4-12062025_011216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278025000009/form4-12062025_011216.xml","form_type":"4"}},{"id":978998,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-06T01:50:19.000Z","date":"2025-12-05","kind":"sale","planned":true,"acquired":false,"shares":6367,"price":31.3304,"value":199480.6568,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.93 to $31.69 per share, inclusive."}],"balance_after":64735,"source":{"system":"sec-edgar","filing":"0001522780-25-000009","document":"form4-12062025_011216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278025000009/form4-12062025_011216.xml","form_type":"4"}},{"id":978997,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-06T01:50:19.000Z","date":"2025-12-04","kind":"sale","planned":true,"acquired":false,"shares":1231,"price":31.3164,"value":38550.4884,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.23 to $31.505 per share, inclusive."}],"balance_after":71102,"source":{"system":"sec-edgar","filing":"0001522780-25-000009","document":"form4-12062025_011216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278025000009/form4-12062025_011216.xml","form_type":"4"}},{"id":978996,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-06T01:50:19.000Z","date":"2025-12-04","kind":"sale","planned":true,"acquired":false,"shares":5222,"price":30.7635,"value":160646.997,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.23 to $31.19 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3, 4, 6, and 7 of this Form 4."}],"balance_after":72333,"source":{"system":"sec-edgar","filing":"0001522780-25-000009","document":"form4-12062025_011216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278025000009/form4-12062025_011216.xml","form_type":"4"}},{"id":978995,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-06T01:50:19.000Z","date":"2025-12-03","kind":"exercise","planned":true,"acquired":true,"shares":26250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":77555,"source":{"system":"sec-edgar","filing":"0001522780-25-000009","document":"form4-12062025_011216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278025000009/form4-12062025_011216.xml","form_type":"4"}},{"id":981484,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-12-04T01:22:08.000Z","date":"2025-12-01","kind":"exercise","planned":false,"acquired":false,"shares":4317,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"21,591 restricted stock units vested on December 1, 2024 and 4,317 vest on December 1, 2025, subject to the reporting person's continued service to the Issuer on each such date."}],"balance_after":0,"derivative":{"expiration_date":"2025-12-01","underlying":"Common Stock","underlying_shares":4317},"source":{"system":"sec-edgar","filing":"0001522780-25-000008","document":"form4-12042025_011205.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278025000008/form4-12042025_011205.xml","form_type":"4"}},{"id":981483,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-04T01:22:08.000Z","date":"2025-12-03","kind":"sale","planned":false,"acquired":false,"shares":651,"price":30.8477,"value":20081.8527,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.815 to $31.17 per share, inclusive."}],"balance_after":51305,"source":{"system":"sec-edgar","filing":"0001522780-25-000008","document":"form4-12042025_011205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278025000008/form4-12042025_011205.xml","form_type":"4"}},{"id":981482,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-04T01:22:08.000Z","date":"2025-12-03","kind":"sale","planned":false,"acquired":false,"shares":419,"price":30.338,"value":12711.622,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.81 to $30.805 per share, inclusive."}],"balance_after":51956,"source":{"system":"sec-edgar","filing":"0001522780-25-000008","document":"form4-12042025_011205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278025000008/form4-12042025_011205.xml","form_type":"4"}},{"id":981481,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-04T01:22:08.000Z","date":"2025-12-02","kind":"sale","planned":false,"acquired":false,"shares":405,"price":30.1419,"value":12207.4695,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.93 to $30.63 per share, inclusive."}],"balance_after":52375,"source":{"system":"sec-edgar","filing":"0001522780-25-000008","document":"form4-12042025_011205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278025000008/form4-12042025_011205.xml","form_type":"4"}},{"id":981480,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-04T01:22:08.000Z","date":"2025-12-02","kind":"sale","planned":false,"acquired":false,"shares":661,"price":29.562,"value":19540.482,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.93 to $29.92 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 through 5."}],"balance_after":52780,"source":{"system":"sec-edgar","filing":"0001522780-25-000008","document":"form4-12042025_011205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278025000008/form4-12042025_011205.xml","form_type":"4"}},{"id":981479,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-04T01:22:08.000Z","date":"2024-12-01","kind":"exercise","planned":false,"acquired":true,"shares":4317,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":53441,"source":{"system":"sec-edgar","filing":"0001522780-25-000008","document":"form4-12042025_011205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278025000008/form4-12042025_011205.xml","form_type":"4"}},{"id":984111,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2025-12-02T14:18:44.000Z","date":"2025-12-01","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on May 18, 2018."}],"balance_after":0,"derivative":{"exercise_price":14.25,"exercise_date":"2017-06-18","expiration_date":"2027-05-18","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001061983-25-000040","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198325000040/form4.xml","form_type":"4"}},{"id":984110,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2025-12-02T14:18:44.000Z","date":"2025-12-01","kind":"exercise","planned":true,"acquired":false,"shares":8064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable as to 8,064 shares divided into equal monthly installments such that the option shall be 100% vested on January 3, 2018."}],"balance_after":0,"derivative":{"exercise_price":12.4,"exercise_date":"2017-02-03","expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":8064},"source":{"system":"sec-edgar","filing":"0001061983-25-000040","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198325000040/form4.xml","form_type":"4"}},{"id":984109,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-02T14:18:44.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":28064,"price":66.72,"value":1872430.08,"ownership":{"direct":true},"balance_after":9977,"source":{"system":"sec-edgar","filing":"0001061983-25-000040","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198325000040/form4.xml","form_type":"4"}},{"id":984108,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-02T14:18:44.000Z","date":"2025-12-01","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":14.25,"value":285000.0,"ownership":{"direct":true},"balance_after":38041,"source":{"system":"sec-edgar","filing":"0001061983-25-000040","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198325000040/form4.xml","form_type":"4"}},{"id":984107,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-02T14:18:44.000Z","date":"2025-12-01","kind":"exercise","planned":true,"acquired":true,"shares":8064,"price":12.4,"value":99993.6,"ownership":{"direct":true},"balance_after":18041,"source":{"system":"sec-edgar","filing":"0001061983-25-000040","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198325000040/form4.xml","form_type":"4"}},{"id":1002648,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2025-11-12T23:50:52.000Z","date":"2025-11-11","kind":"exercise","planned":true,"acquired":false,"shares":5175,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable as to 5,175 shares divided into equal monthly installments such that the option shall be 100% vested on January 1, 2017."}],"balance_after":0,"derivative":{"exercise_price":9.66,"exercise_date":"2016-08-01","expiration_date":"2026-07-01","underlying":"Common Stock","underlying_shares":5175},"source":{"system":"sec-edgar","filing":"0001061983-25-000031","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198325000031/form4.xml","form_type":"4"}},{"id":1002647,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-11-12T23:50:52.000Z","date":"2025-11-11","kind":"sale","planned":true,"acquired":false,"shares":5175,"price":65.08,"value":336789.0,"ownership":{"direct":true},"balance_after":9977,"source":{"system":"sec-edgar","filing":"0001061983-25-000031","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198325000031/form4.xml","form_type":"4"}},{"id":1002646,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-11-12T23:50:52.000Z","date":"2025-11-11","kind":"exercise","planned":true,"acquired":true,"shares":5175,"price":9.66,"value":49990.5,"ownership":{"direct":true},"balance_after":15152,"source":{"system":"sec-edgar","filing":"0001061983-25-000031","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198325000031/form4.xml","form_type":"4"}},{"id":1017800,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-10-16T20:34:47.000Z","date":"2025-10-15","kind":"grant","planned":false,"acquired":true,"shares":199,"price":62.8,"value":12497.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Director equity in lieu of cash retainer program."}],"balance_after":9977,"source":{"system":"sec-edgar","filing":"0001061983-25-000011","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198325000011/form4.xml","form_type":"4"}},{"id":1020229,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-10T20:12:24.000Z","date":"2025-10-08","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested as to 1/4th of the total award on  October 17, 2018, with another 1/48th of the total award vesting monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date.  Accordingly, this stock option is now fully vested."}],"balance_after":542801,"derivative":{"exercise_price":0.6,"expiration_date":"2028-04-02","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001522780-25-000007","document":"form4-10102025_081021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278025000007/form4-10102025_081021.xml","form_type":"4"}},{"id":1020228,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-10T20:12:24.000Z","date":"2025-10-08","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":30,"value":750000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2024."}],"balance_after":49124,"source":{"system":"sec-edgar","filing":"0001522780-25-000007","document":"form4-10102025_081021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278025000007/form4-10102025_081021.xml","form_type":"4"}},{"id":1020227,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-10T20:12:24.000Z","date":"2025-10-08","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":0.6,"value":15000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2024."}],"balance_after":74124,"source":{"system":"sec-edgar","filing":"0001522780-25-000007","document":"form4-10102025_081021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278025000007/form4-10102025_081021.xml","form_type":"4"}},{"id":1022188,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-07T20:26:59.000Z","date":"2025-10-03","kind":"sale","planned":true,"acquired":false,"shares":42461,"price":25.0867,"value":1065206.3687,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":49124,"source":{"system":"sec-edgar","filing":"0001522780-25-000004","document":"form4-10072025_081055.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278025000004/form4-10072025_081055.xml","form_type":"4"}},{"id":1023613,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-10-06T20:27:58.000Z","date":"2025-10-06","kind":"sale","planned":true,"acquired":false,"shares":6757,"price":60,"value":405420.0,"ownership":{"direct":true},"balance_after":9778,"source":{"system":"sec-edgar","filing":"0001061983-25-000008","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198325000008/form4.xml","form_type":"4"}},{"id":1030785,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-09-30T20:33:53.000Z","date":"2025-09-30","kind":"sale","planned":true,"acquired":false,"shares":6695,"price":55.08,"value":368760.6,"ownership":{"direct":true},"balance_after":16535,"source":{"system":"sec-edgar","filing":"0001061983-25-000006","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198325000006/form4.xml","form_type":"4"}},{"id":1046796,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-09-05T20:10:22.000Z","date":"2025-09-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":144000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"kind","element":"transactionCoding","label":"F4","text":"The reported transaction represents a disposition to the Issuer of equity securities that is exempt pursuant to Rule 16b-3(e) and 16b-6(d).  The entire equity award was canceled for no consideration by mutual agreement of the reporting person and the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported transaction represents a disposition to the Issuer of equity securities that is exempt pursuant to Rule 16b-3(e) and 16b-6(d).  The entire equity award was canceled for no consideration by mutual agreement of the reporting person and the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the terms under which it was granted, the award was scheduled to vest as to 1/4 of the total award annually beginning on March 15, 2026, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":0,"derivative":{"expiration_date":"2029-03-20","underlying":"Common Stock","underlying_shares":144000},"source":{"system":"sec-edgar","filing":"0001415889-25-023792","document":"form4-09052025_080918.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925023792/form4-09052025_080918.xml","form_type":"4"}},{"id":1046795,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-09-05T20:10:22.000Z","date":"2025-09-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":178500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents a disposition to the Issuer of equity securities that is exempt pursuant to Rule 16b-3(e) and 16b-6(d). The equity award was partially canceled for no consideration by mutual agreement of the reporting person and the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transaction represents a disposition to the Issuer of equity securities that is exempt pursuant to Rule 16b-3(e) and 16b-6(d). The equity award was partially canceled for no consideration by mutual agreement of the reporting person and the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option began vesting on April 15, 2025. Pursuant to the terms of the initial grant, the original number of shares subject to the option vests in ratable increments monthly and the option shall be fully vested on December 15, 2026, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":37500,"derivative":{"exercise_price":8.33,"expiration_date":"2035-03-19","underlying":"Common Stock","underlying_shares":178500},"source":{"system":"sec-edgar","filing":"0001415889-25-023792","document":"form4-09052025_080918.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925023792/form4-09052025_080918.xml","form_type":"4"}},{"id":1049567,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-03T21:51:54.000Z","date":"2025-09-03","kind":"sale","planned":true,"acquired":false,"shares":45996,"price":20.1291,"value":925858.0836,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.40, inclusive."}],"balance_after":91585,"source":{"system":"sec-edgar","filing":"0001415889-25-023590","document":"form4-09032025_090950.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925023590/form4-09032025_090950.xml","form_type":"4"}},{"id":1049566,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-03T21:51:54.000Z","date":"2025-09-02","kind":"sale","planned":true,"acquired":false,"shares":14860,"price":20.1386,"value":299259.596,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4."}],"balance_after":137581,"source":{"system":"sec-edgar","filing":"0001415889-25-023590","document":"form4-09032025_090950.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925023590/form4-09032025_090950.xml","form_type":"4"}},{"id":1049565,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-03T21:51:54.000Z","date":"2025-08-29","kind":"sale","planned":true,"acquired":false,"shares":1029,"price":20,"value":20580.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2024."}],"balance_after":152441,"source":{"system":"sec-edgar","filing":"0001415889-25-023590","document":"form4-09032025_090950.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925023590/form4-09032025_090950.xml","form_type":"4"}},{"id":1051856,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-09-02T20:41:40.000Z","date":"2025-09-02","kind":"sale","planned":true,"acquired":false,"shares":6756,"price":50,"value":337800.0,"ownership":{"direct":true},"balance_after":23230,"source":{"system":"sec-edgar","filing":"0001127602-25-021074","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225021074/form4.xml","form_type":"4"}},{"id":1060214,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-20T20:12:13.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":12126,"price":18.238,"value":221153.988,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.50 per share, inclusive."}],"balance_after":153470,"source":{"system":"sec-edgar","filing":"0001415889-25-022441","document":"form4-08202025_080810.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925022441/form4-08202025_080810.xml","form_type":"4"}},{"id":1063877,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Performance Stock Units","published_at":"2025-08-19T00:23:23.000Z","date":"2025-08-14","kind":"exercise","planned":false,"acquired":false,"shares":26250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit represents a right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Half the award vests on August 14, 2025 and the remainder shall vest on August 14, 2026, subject to the reporting person's continued service to the Issuer on the relevant vesting date."}],"balance_after":26250,"derivative":{"expiration_date":"2026-08-14","underlying":"Common Stock","underlying_shares":26250},"source":{"system":"sec-edgar","filing":"0001415889-25-022225","document":"form4-08192025_120819.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925022225/form4-08192025_120819.xml","form_type":"4"}},{"id":1063876,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Performance Stock Units","published_at":"2025-08-19T00:23:23.000Z","date":"2025-08-14","kind":"grant","planned":false,"acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit represents a right to receive one share of the Issuer's common stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This award represents a grant of restricted stock units upon the achievement of certain performance criteria as certified by the Issuer's compensation committee on the Transaction Date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Half the award vests on August 14, 2025 and the remainder shall vest on August 14, 2026, subject to the reporting person's continued service to the Issuer on the relevant vesting date."}],"balance_after":52500,"derivative":{"expiration_date":"2026-08-14","underlying":"Common Stock","underlying_shares":52500},"source":{"system":"sec-edgar","filing":"0001415889-25-022225","document":"form4-08192025_120819.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925022225/form4-08192025_120819.xml","form_type":"4"}},{"id":1063875,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-19T00:23:23.000Z","date":"2025-08-14","kind":"exercise","planned":false,"acquired":true,"shares":26250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":165596,"source":{"system":"sec-edgar","filing":"0001415889-25-022225","document":"form4-08192025_120819.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925022225/form4-08192025_120819.xml","form_type":"4"}},{"id":1086853,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-16T21:43:05.000Z","date":"2025-07-15","kind":"grant","planned":false,"acquired":true,"shares":328,"price":38.01,"value":12467.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Director equity in lieu of cash retainer program."}],"balance_after":29986,"source":{"system":"sec-edgar","filing":"0001127602-25-019288","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225019288/form4.xml","form_type":"4"}},{"id":1112934,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T22:37:29.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":10034,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest in full on the first to occur of June 10, 2026 or the Issuer's 2026 annual meeting of stockholders, in each case subject to the Reporting Person's continuous service to the Issuer through such date."}],"balance_after":10034,"derivative":{"exercise_price":33.62,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":10034},"source":{"system":"sec-edgar","filing":"0001599901-25-000125","document":"wk-form4_1749767841.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1522780/000159990125000125/wk-form4_1749767841.xml","form_type":"4"}},{"id":1112933,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T22:37:29.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":6692,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in full on the first to occur of June 10, 2026 or the Issuer's 2026 annual meeting of stockholders, in each case subject to the Reporting Person's continuous service to the Issuer through such date."}],"balance_after":6692,"source":{"system":"sec-edgar","filing":"0001599901-25-000125","document":"wk-form4_1749767841.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1522780/000159990125000125/wk-form4_1749767841.xml","form_type":"4"}},{"id":1121842,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-05T20:42:43.000Z","date":"2025-06-05","kind":"sale","planned":true,"acquired":false,"shares":3636,"price":32.1,"value":116715.6,"ownership":{"direct":true},"balance_after":29658,"source":{"system":"sec-edgar","filing":"0001127602-25-016870","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225016870/form4.xml","form_type":"4"}},{"id":1149742,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2025-05-14T23:35:13.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":10880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Comprised of stock options that will vest monthly in equal installments over a period commencing on the grant date and ending on the earlier to occur of (x) the one-year anniversary of the date of the grant and (y) the date of the issuer's annual meeting of stockholders for the calendar year immediately subsequent to the grant date, subject to the director's continuous service as a member of the issuer's Board of Directors."}],"balance_after":10880,"derivative":{"exercise_price":30,"exercise_date":"2025-06-16","expiration_date":"2035-05-13","underlying":"Common Stock","underlying_shares":10880},"source":{"system":"sec-edgar","filing":"0001127602-25-014360","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225014360/form4.xml","form_type":"4"}},{"id":1149741,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-14T23:35:13.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":7333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Comprised of restricted stock units (\"RSUs\") that will vest in one installment on the earlier to occur of (x) the one-year anniversary of the grant date and (y) the date of the issuer's annual meeting of stockholders for the calendar year immediately subsequent to the grant date, subject to the director's continuous service as a member of the issuer's Board of Directors. RSUs convert to shares of common stock on a 1:1 basis upon vesting."}],"balance_after":33294,"source":{"system":"sec-edgar","filing":"0001127602-25-014360","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225014360/form4.xml","form_type":"4"}},{"id":1171207,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-04-16T20:05:13.000Z","date":"2025-04-15","kind":"grant","planned":false,"acquired":true,"shares":324,"price":38.56,"value":12493.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired pursuant to Director Stock in lieu of Cash Retainer Program."}],"balance_after":25961,"source":{"system":"sec-edgar","filing":"0001127602-25-012114","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225012114/form4.xml","form_type":"4"}},{"id":1195682,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-03-20T22:15:17.000Z","date":"2025-03-20","kind":"grant","planned":false,"acquired":true,"shares":144000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The award vests as to 1/4 of the total award annually beginning on March 15, 2026, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":144000,"derivative":{"expiration_date":"2029-03-20","underlying":"Common Stock","underlying_shares":144000},"source":{"system":"sec-edgar","filing":"0001415889-25-008711","document":"form4-03202025_100313.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925008711/form4-03202025_100313.xml","form_type":"4"}},{"id":1195681,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-03-20T22:15:17.000Z","date":"2025-03-20","kind":"grant","planned":false,"acquired":true,"shares":216000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option shall vest as to 1/48 of the total award on April 15, 2025, with 1/48 vesting on each monthly anniversary thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":216000,"derivative":{"exercise_price":8.33,"expiration_date":"2035-03-19","underlying":"Common Stock","underlying_shares":216000},"source":{"system":"sec-edgar","filing":"0001415889-25-008711","document":"form4-03202025_100313.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925008711/form4-03202025_100313.xml","form_type":"4"}},{"id":1195680,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-20T22:15:17.000Z","date":"2025-03-19","kind":"sale","planned":false,"acquired":false,"shares":8907,"price":8.27,"value":73660.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.06 to $8.95 per share, inclusive."}],"balance_after":139346,"source":{"system":"sec-edgar","filing":"0001415889-25-008711","document":"form4-03202025_100313.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925008711/form4-03202025_100313.xml","form_type":"4"}},{"id":1195679,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-20T22:15:17.000Z","date":"2025-03-18","kind":"sale","planned":false,"acquired":false,"shares":10382,"price":8.67,"value":90011.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.11 to $8.925 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnote 3."}],"balance_after":148253,"source":{"system":"sec-edgar","filing":"0001415889-25-008711","document":"form4-03202025_100313.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925008711/form4-03202025_100313.xml","form_type":"4"}},{"id":1199729,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2025-03-18T20:07:08.000Z","date":"2025-03-15","kind":"exercise","planned":false,"acquired":false,"shares":26250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The award vested or vests as to 1/4 of the total award annually beginning on March 15, 2025, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":78750,"derivative":{"expiration_date":"2028-03-15","underlying":"Common Stock","underlying_shares":26250},"source":{"system":"sec-edgar","filing":"0001415889-25-008355","document":"form4-03182025_080305.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925008355/form4-03182025_080305.xml","form_type":"4"}},{"id":1199728,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2025-03-18T20:07:08.000Z","date":"2025-03-15","kind":"exercise","planned":false,"acquired":false,"shares":35500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award vested or vests as to 1/4 of the total shares annually beginning March 15, 2024, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":71000,"derivative":{"expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":35500},"source":{"system":"sec-edgar","filing":"0001415889-25-008355","document":"form4-03182025_080305.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925008355/form4-03182025_080305.xml","form_type":"4"}},{"id":1199727,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-03-18T20:07:08.000Z","date":"2025-03-15","kind":"exercise","planned":false,"acquired":true,"shares":26250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":158635,"source":{"system":"sec-edgar","filing":"0001415889-25-008355","document":"form4-03182025_080305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925008355/form4-03182025_080305.xml","form_type":"4"}},{"id":1199726,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-03-18T20:07:08.000Z","date":"2025-03-15","kind":"exercise","planned":false,"acquired":true,"shares":35500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":132385,"source":{"system":"sec-edgar","filing":"0001415889-25-008355","document":"form4-03182025_080305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925008355/form4-03182025_080305.xml","form_type":"4"}},{"id":1311568,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-01-06T21:25:04.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":255,"price":48.93,"value":12477.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Director Stock in Lieu of Cash Retainer Program"}],"balance_after":25637,"source":{"system":"sec-edgar","filing":"0001127602-25-000765","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225000765/form4.xml","form_type":"4"}},{"id":1318614,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-01-02T21:14:59.000Z","date":"2024-12-30","kind":"exercise","planned":false,"acquired":false,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option became fully vested as of October 17, 2022."}],"balance_after":567801,"derivative":{"exercise_price":0.6,"expiration_date":"2028-04-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001415889-25-000084","document":"form4-01022025_090156.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925000084/form4-01022025_090156.xml","form_type":"4"}},{"id":1318613,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-01-02T21:14:59.000Z","date":"2024-12-30","kind":"exercise","planned":false,"acquired":true,"shares":35000,"price":0.6,"value":21000.0,"ownership":{"direct":true},"balance_after":96885,"source":{"system":"sec-edgar","filing":"0001415889-25-000084","document":"form4-01022025_090156.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925000084/form4-01022025_090156.xml","form_type":"4"}},{"id":1335538,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-12-11T21:04:51.000Z","date":"2024-12-09","kind":"sale","planned":false,"acquired":false,"shares":6786,"price":12.9912,"value":88158.2832,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.99 to $13.13 per share, inclusive."}],"balance_after":61885,"source":{"system":"sec-edgar","filing":"0001415889-24-028928","document":"form4-12112024_091247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924028928/form4-12112024_091247.xml","form_type":"4"}},{"id":1337167,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-12-11T00:00:44.000Z","date":"2024-12-06","kind":"sale","planned":false,"acquired":false,"shares":6170,"price":12.7775,"value":78837.175,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.93 to $13.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":68671,"source":{"system":"sec-edgar","filing":"0001415889-24-028890","document":"form4-12112024_121241.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924028890/form4-12112024_121241.xml","form_type":"4"}},{"id":1337166,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Performance Stock Units","published_at":"2024-12-10T23:59:32.000Z","date":"2024-12-03","kind":"exercise","planned":false,"acquired":false,"shares":26250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit represents a right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Half the award vests on December 3, 2024 and the remainder shall vest on December 3, 2025, subject to the reporting person's continued service to the Issuer on the relevant vesting date."}],"balance_after":26250,"derivative":{"expiration_date":"2025-12-03","underlying":"Common Stock","underlying_shares":26250},"source":{"system":"sec-edgar","filing":"0001415889-24-028889","document":"form4a-12102024_111228.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924028889/form4a-12102024_111228.xml","form_type":"4/A","original_submission_date":"2024-12-05"}},{"id":1337165,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Performance Stock Units","published_at":"2024-12-10T23:59:32.000Z","date":"2024-12-03","kind":"grant","planned":false,"acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit represents a right to receive one share of the Issuer's common stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This award represents a grant of restricted stock units upon the achievement of certain performance criteria as certified by the Issuer's compensation committee on the Transaction Date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Half the award vests on December 3, 2024 and the remainder shall vest on December 3, 2025, subject to the reporting person's continued service to the Issuer on the relevant vesting date."}],"balance_after":52500,"derivative":{"expiration_date":"2025-12-03","underlying":"Common Stock","underlying_shares":52500},"source":{"system":"sec-edgar","filing":"0001415889-24-028889","document":"form4a-12102024_111228.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924028889/form4a-12102024_111228.xml","form_type":"4/A","original_submission_date":"2024-12-05"}},{"id":1337164,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-12-10T23:59:32.000Z","date":"2024-12-03","kind":"exercise","planned":false,"acquired":true,"shares":26250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":74841,"source":{"system":"sec-edgar","filing":"0001415889-24-028889","document":"form4a-12102024_111228.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924028889/form4a-12102024_111228.xml","form_type":"4/A","original_submission_date":"2024-12-05"}},{"id":1341574,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Performance Stock Units","published_at":"2024-12-05T21:20:12.000Z","date":"2024-12-03","kind":"exercise","planned":false,"acquired":false,"shares":26500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit represents a right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Half the award vests on December 3, 2024 and the remainder shall vest on December 3, 2025, subject to the reporting person's continued service to the Issuer on the relevant vesting date."}],"balance_after":26500,"derivative":{"expiration_date":"2025-12-03","underlying":"Common Stock","underlying_shares":26500},"source":{"system":"sec-edgar","filing":"0001415889-24-028397","document":"form4-12052024_091208.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924028397/form4-12052024_091208.xml","form_type":"4"}},{"id":1341573,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Performance Stock Units","published_at":"2024-12-05T21:20:12.000Z","date":"2024-12-03","kind":"grant","planned":false,"acquired":true,"shares":53000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit represents a right to receive one share of the Issuer's common stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This award represents a grant of restricted stock units upon the achievement of certain performance criteria as certified by the Issuer's compensation committee on the Transaction Date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Half the award vests on December 3, 2024 and the remainder shall vest on December 3, 2025, subject to the reporting person's continued service to the Issuer on the relevant vesting date."}],"balance_after":53000,"derivative":{"expiration_date":"2025-12-03","underlying":"Common Stock","underlying_shares":53000},"source":{"system":"sec-edgar","filing":"0001415889-24-028397","document":"form4-12052024_091208.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924028397/form4-12052024_091208.xml","form_type":"4"}},{"id":1341572,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-12-05T21:20:12.000Z","date":"2024-12-03","kind":"exercise","planned":false,"acquired":true,"shares":26500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":75091,"source":{"system":"sec-edgar","filing":"0001415889-24-028397","document":"form4-12052024_091208.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924028397/form4-12052024_091208.xml","form_type":"4"}},{"id":1344960,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2024-12-03T21:13:00.000Z","date":"2024-12-01","kind":"exercise","planned":false,"acquired":false,"shares":21591,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"21,591 restricted stock units will vest on December 1, 2024 and 4,317 will vest on December 1, 2025, subject to the reporting person's continued service to the Issuer on each such date."}],"balance_after":4317,"derivative":{"expiration_date":"2025-12-01","underlying":"Common Stock","underlying_shares":21591},"source":{"system":"sec-edgar","filing":"0001415889-24-028070","document":"form4-12032024_091257.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924028070/form4-12032024_091257.xml","form_type":"4"}},{"id":1344959,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-12-03T21:13:00.000Z","date":"2024-12-01","kind":"exercise","planned":false,"acquired":true,"shares":21591,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":48591,"source":{"system":"sec-edgar","filing":"0001415889-24-028070","document":"form4-12032024_091257.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924028070/form4-12032024_091257.xml","form_type":"4"}},{"id":1392517,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-10-03T21:26:27.000Z","date":"2024-10-01","kind":"grant","planned":false,"acquired":true,"shares":237,"price":52.6,"value":12466.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Stock award in lieu of cash retainer payment."}],"balance_after":25382,"source":{"system":"sec-edgar","filing":"0001127602-24-025195","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760224025195/form4.xml","form_type":"4"}},{"id":1460774,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-07-04T00:04:01.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":228,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Stock award in lieu of cash retainer payment."}],"balance_after":25145,"source":{"system":"sec-edgar","filing":"0001127602-24-020148","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760224020148/form4.xml","form_type":"4"}},{"id":1478591,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-14T23:09:38.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":13489,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on the board of directors of the Issuer through such vesting date."}],"balance_after":13489,"derivative":{"exercise_price":39.96,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":13489},"source":{"system":"sec-edgar","filing":"0001599901-24-000103","document":"wk-form4_1718406571.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1522780/000159990124000103/wk-form4_1718406571.xml","form_type":"4"}},{"id":1486734,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2024-06-07T20:42:34.000Z","date":"2024-03-27","kind":"grant","planned":false,"acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The award vests as to 1/4 of the total award annually beginning on March 15, 2025, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":105000,"derivative":{"expiration_date":"2028-03-15","underlying":"Common Stock","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001415889-24-016010","document":"form4-06072024_080631.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924016010/form4-06072024_080631.xml","form_type":"4"}},{"id":1486733,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-06-07T20:42:34.000Z","date":"2024-03-27","kind":"grant","planned":false,"acquired":true,"shares":159000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested or vests as to 1/48 of the total award on April 15, 2024, with 1/48 vesting on each monthly anniversary thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":159000,"derivative":{"exercise_price":14.17,"expiration_date":"2034-03-26","underlying":"Common Stock","underlying_shares":159000},"source":{"system":"sec-edgar","filing":"0001415889-24-016010","document":"form4-06072024_080631.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924016010/form4-06072024_080631.xml","form_type":"4"}},{"id":1505430,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-05-22T20:17:23.000Z","date":"2024-05-20","kind":"sale","planned":true,"acquired":false,"shares":2664,"price":16.0457,"value":42745.7448,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 26, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":27000,"source":{"system":"sec-edgar","filing":"0001415889-24-014087","document":"form4-05222024_080510.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924014087/form4-05222024_080510.xml","form_type":"4"}},{"id":1505429,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-05-22T20:17:23.000Z","date":"2024-05-20","kind":"sale","planned":true,"acquired":false,"shares":39686,"price":15.3904,"value":610783.4144,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 26, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":29664,"source":{"system":"sec-edgar","filing":"0001415889-24-014087","document":"form4-05222024_080510.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924014087/form4-05222024_080510.xml","form_type":"4"}},{"id":1514785,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2024-05-16T22:03:05.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":3636,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3636,"derivative":{"exercise_price":60.5,"exercise_date":"2024-06-17","expiration_date":"2034-05-15","underlying":"Common Stock","underlying_shares":3636},"source":{"system":"sec-edgar","filing":"0001127602-24-015721","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760224015721/form4.xml","form_type":"4"}}],"next_cursor":"2024-05-16T22:03:05.000000Z,1514785"}